Form 4 for CLNN Clene Inc.
Accepted 2026-04-17 20:17:12 ET · period of report 2026-04-15 · accession 0001835544-26-000015 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2026-04-17 20:17 | 2026-04-15+ | CLNN | Ugwumba Chidozie | 10% | S - Sale | $6.43 | -39.2K | 362.7K | -10% | -$251.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-04-15 | S | D | 6,374 | $6.48 | 395,517 | I By SymBiosis II, LLC | — | — | |
| 2 | Common | Common Stock | 2026-04-16 | S | D | 7,748 | $6.40 | 387,769 | I By SymBiosis II, LLC | — | — | |
| 3 | Common | Common Stock | 2026-04-17 | S | D | 25,040 | $6.43 | 362,729 | I By SymBiosis II, LLC | — | — |